Biotinylated Monoclonal Anti IGFBP-4 Antibody
| Catalog number: | B2019301 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Biotin Monoclonal Anti IGFBP-4 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Bulut I, Ozseker ZF, Coskun A, Serteser M, Unsal I. Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab J Asthma. 2018 Oct;55(10):1116-1121.
- Oh YS, Kim EJ, Schaffer BS, Kang YH, Binderup L, MacDonald RG, Park JH. Synthetic low-calcaemic vitamin D(3) analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells Mol Cell Endocrinol. 2001 Oct 25;183(1-2):141-9.
- Cho HJ, Lee HS, Chung CK, Kang YH, Ha YL, Park HS, Park JH. trans-10, cis-12 conjugated linoleic acid reduces insulin-like growth factor-II secretion in HT-29 human colon cancer cells J Med Food. 2003 Fall;6(3):193-9.
- Richardson RL, Hausman GJ, Wright JT. Growth factor regulation of insulin-like growth factor (IGF) binding proteins (IGFBP) and preadipocyte differentiation in porcine stromal-vascular cell cultures Growth Dev Aging. 1998 Spring-Summer;62(1-2):3-12.
- Moreno MJ, Ball M, Andrade MF, McDermid A, Stanimirovic DB. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells Glia. 2006 Jun;53(8):845-57.
- Hjortebjerg R, Thomsen KL, Agnholt J, Frystyk J. The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis BMC Gastroenterol. 2019 Jun 3;19(1):83.
- Bulut I, Ozseker ZF, Coskun A, Serteser M, Unsal I. Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumab J Asthma. 2018 Oct;55(10):1116-1121.
- Rivera GM, Fortune JE. Selection of the dominant follicle and insulin-like growth factor (IGF)-binding proteins: evidence that pregnancy-associated plasma protein A contributes to proteolysis of IGF-binding protein 5 in bovine follicular fluid Endocrinology. 2003 Feb;144(2):437-46.
- Contois LW, Akalu A, Caron JM, Tweedie E, Cretu A, Henderson T, Liaw L, Friesel R, Vary C, Brooks PC. Inhibition of tumor-associated v3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo Angiogenesis. 2015 Jan;18(1):31-46.
